ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 191 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,542 | -95.8% | 15,944 | -85.9% | 0.01% | -96.7% |
| Q3 2022 | $1,217,000 | -46.0% | 112,701 | -43.0% | 0.18% | -7.5% |
| Q2 2022 | $2,254,000 | +2.4% | 197,719 | -18.2% | 0.20% | +5.3% |
| Q1 2022 | $2,201,000 | -20.7% | 241,592 | +29.8% | 0.19% | -10.4% |
| Q4 2021 | $2,776,000 | +84.0% | 186,082 | +216.9% | 0.21% | +95.4% |
| Q3 2021 | $1,509,000 | -64.7% | 58,727 | -64.2% | 0.11% | -61.7% |
| Q2 2021 | $4,273,000 | +48.9% | 163,828 | +101.6% | 0.28% | +36.9% |
| Q1 2021 | $2,869,000 | -15.0% | 81,265 | -39.2% | 0.21% | -9.6% |
| Q4 2020 | $3,376,000 | -7.7% | 133,741 | +38.0% | 0.23% | -5.4% |
| Q3 2020 | $3,656,000 | +800.5% | 96,943 | +519.8% | 0.24% | +864.0% |
| Q4 2019 | $406,000 | – | 15,640 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |